SCHEMBL23726367

SCHEMBL23726367

O=C1CCC(CN(Cc2cc(=O)n3cc(Br)ccc3n2)C(=O)O)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PSD A5PKW4 2/20 0.44
▸ RXFP1 Q9HBX9 9/20 0.43
▸ POLB P06746 5/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ AHR P35869 1/20 0.42
▸ TDP1 Q9NUW8 3/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RECQL P46063 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25664421 0.87 KDM4E (0.47) KDM4ENPC1GAARAB9APSD
SCHEMBL23726761 0.87 METTL3 (0.36) KDM4ENPC1GAARAB9ARXFP1
SCHEMBL23726764 0.87 METTL3 (0.36) KDM4ENPC1GAARAB9ARXFP1
SCHEMBL23725967 0.80 MEN1 (0.34) KDM4EPOLBALDH1A1MAPK1NPSR1
SCHEMBL23726593 0.77 KDM4E (0.45) KDM4ENPC1GAARAB9APSD
SCHEMBL23726369 0.76 KDM4E (0.55) KDM4ENPC1GAARAB9APSD
SCHEMBL25673165 0.74 IRAK4 (0.36) KDM4ENPC1GAARAB9ARXFP1
SCHEMBL23727493 0.73 KDM4E (0.33) KDM4ENPC1GAARAB9AMAPK1
SCHEMBL23725743 0.72 IRAK4 (0.36) KDM4EPOLBSMN1; SMN2ALDH1A1MAPK1
SCHEMBL23725488 0.70 KCNA5 (0.41) KDM4EPOLBALDH1A1MAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 — — US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 — — EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL KDM4E 224/4885NPC1 165/4885GAA 1601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback